Bond.az White LogoBond.az Black Logo

FuriosaAI Partners with Broadcom on 3rd Gen AI Chip

FuriosaAI partners with Broadcom to develop 3rd gen AI chip with 2nm process and HBM4 memory. Sampling starts H1 2028.

Harper Clark
ByHarper Clark- Senior Editor
|
0

MOUNTAIN VIEW, Calif. - FuriosaAI announced a partnership with Broadcom to develop its third-generation AI accelerator chip.

The collaboration combines FuriosaAI's Tensor Contraction Processor architecture with Broadcom's networking technology to create a multi-die chiplet system for AI inference workloads in data centers.

FuriosaAI's current product, RNGD, is a 180-watt, PCIe-based accelerator manufactured using TSMC's 5nm process. The chip is in mass production and deployed by Samsung SDS and LG AI Research.

"Inference performance is no longer defined solely by raw compute. It is increasingly a function of data reuse and communication efficiency across servers and racks," said Charlie Kawwas, president of Broadcom's Semiconductor Solutions Group.

The third-generation chip will feature a 2nm compute die and HBM4/4E memory, using Broadcom's packaging technology to integrate multiple silicon dies.

"Having proven the performance and efficiency of our architecture with RNGD, our second-generation chip now in mass production with TSMC, we will deliver a third-generation inference solution," said June Paik, FuriosaAI cofounder and CEO.

Sampling of the third-generation chip is scheduled to begin in the first half of 2028.

More News
Today / 13:33
|
686

Hippocratic AI hits 10 million patient calls

Hippocratic AI's Polaris system hits 10 million patient calls on DigitalOcean with 99.9% safety score. Over 180 million interactions handled.

0
Today / 13:32
|
526

Paramount Gets Consents for WBD Debt Amendments

Paramount gets consents for WBD debt amendments involving $17.2 billion notes. Details on exchange offers and tender offers.

0
Today / 13:31
|
400

Mastercard Gets NY BitLicense

Mastercard subsidiary receives New York BitLicense for digital asset activities. Regulatory approval for crypto operations.

0
Today / 12:34
|
406

Ernexa Advances ERNA-101 Toward Q3 IND Filing

Ernexa Therapeutics advances ERNA-101 toward Q3 IND filing. The company has completed process development and moved to GMP manufacturing for clinical trials.

0
Today / 12:33
|
604

Alpha Modus Launches AI Platform for Physical Retail Stores

Alpha Modus launches ARIA, an AI platform for physical retail stores. It uses existing infrastructure and delivers real-time decisions.

0
Today / 12:32
|
478

VolitionRx Q1 Revenue Surges 300%, Nears Vet Milestone

VolitionRx Q1 revenue jumps 300% to $1M. Company nears vet milestone with Nu.Q test. Stock up 18%. Analyst targets $16-$24.

0
Today / 11:36
|
615

ProLogium SPAC Merger Valued at $3.8B

ProLogium, a solid-state battery manufacturer, goes public via SPAC merger at $3.8 billion valuation on Nasdaq.

0
Today / 11:34
|
415

Newcleo to Go Public via SPAC Merger at $2.4B Valuation

Newcleo merges with SPAC NewHold at $2.4B valuation, lists on Nasdaq as NWCL. PIPE of $220M included. Transaction expected to close in 2026.

0
Today / 11:33
|
285

Erdene publishes 2026 shareholder letter, schedules meeting

Erdene Resource Development Corp. published its 2026 shareholder letter and scheduled its annual meeting. Details on the Bayan Khundii gold mine operations.

0
Today / 09:02
|
855

FP-001 42 mg Clinical Trial Completed

Foresee Pharmaceuticals completes Phase 3 trial for FP-001 42 mg for precocious puberty. FDA submission planned for 2026. CAMCEVI 21mg approved in Europe.

0
Today / 07:05
|
446

Eden Research director resigns

Eden Research non-executive director Derek McAllan resigns due to ill health. Rob Cridland appointed interim Audit Committee chair.

0
Today / 06:31
|
362

HgCapital Trust invests £11m in Rightsline software

HgCapital Trust invests £11 million in Rightsline, a rights and royalties management software provider, as part of a $500M growth round.

0
...
FuriosaAI Partners with Broadcom on 3rd Gen AI Chip | Bond.az